Generate Biomedicines Stock Price, News & Analysis
Company Description
Generate Biomedicines (NASDAQ: GENB) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.6B, ranking #2,461 among all listed U.S. companies by market cap.
GENB stock has declined 4.2% over the past year. Shares last traded at $12.12.
This page provides a comprehensive overview of GENB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Generate Biomedicines (GENB) stock last traded at $12.12, down 0.25% from the previous close. Over the past 12 months, the stock has lost 4.2%. At a market capitalization of $1.6B, GENB is classified as a small-cap stock with approximately 127.5M shares outstanding.
GENB Rankings
Latest News
Generate Biomedicines has 1 recent news article. Key topics include IPO, offering. View all GENB news →
SEC Filings
Generate Biomedicines has filed 5 recent SEC filings, including 4 Form 4, 1 Form 3. The most recent filing was submitted on March 12, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GENB SEC filings →
Insider Radar
Insider buying activity at Generate Biomedicines over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Generate Biomedicines (GENB) currently stands at 1.4 million shares, up 52.5% from the previous reporting period, representing 5.4% of the float. Over the past 12 months, short interest has increased by 52.5%.
Days to Cover History
Days to cover for Generate Biomedicines (GENB) currently stands at 3.9 days, up 290% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 290% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.9 days.
GENB Company Profile & Sector Positioning
Generate Biomedicines (GENB) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #4,300 among all tracked companies.